Literature DB >> 23651347

Adrenomedullin and angiopoietin-1 additively restore erectile function in diabetic rats: comparison with the combination therapy of vascular endothelial growth factor and angiopoietin-1.

Hiroaki Nishimatsu1, Etsu Suzuki, Akira Nomiya, Aya Niimi, Motofumi Suzuki, Tetsuya Fujimura, Hiroshi Fukuhara, Yukio Homma.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) is a major health problem. We have shown that adrenomedullin (AM) restores erectile function in diabetic rats. AIM: The aim of this study is to explore a better treatment for ED, we examined whether combination of AM and angiopoietin-1 (Ang-1) was more effective to treat ED than treatment with AM alone or Ang-1 alone. We also compared the effect of the combination therapy with that of treatment with vascular endothelial growth factor-A (VEGF-A).
METHODS: Male Wistar rats were injected with streptozotocin (STZ) to induce diabetes. Adenoviruses expressing AM (AdAM), Ang-1 (AdAng-1), and VEGF-A (AdVEGF-A) were injected into the penis 6 weeks after STZ administration. Erectile function, penile histology, and protein expression were analyzed 4 weeks after the injection of the adenoviruses. MAIN OUTCOME MEASURES: Intracavernous pressure and mean arterial pressure were measured to evaluate erectile function. The morphology of the penis was analyzed by Elastica van Gieson stain and immunohistochemistry. The expression of α-smooth muscle actin (SMA), VE-cadherin and type I collagen was assessed by Western blot analysis.
RESULTS: Infection with AdAM plus AdAng-1 more effectively restored erectile function than infection with AdAM alone or AdAng-1 alone. This combination therapy restored erectile function to a level similar to that observed in the age-matched Wistar rats. Expression of SMA and VE-cadherin increased more significantly in the AdAM plus AdAng-1-treated group than in the AdAM- or AdAng-1-treated group. Although AdVEGF-A infection restored erectile function significantly, it also caused enlargement of the trabeculae of the cavernous body, aberrant angiogenesis, and overproduction of type I collagen.
CONCLUSIONS: These results suggested that combination therapy with AM and Ang-1 potently restored erectile function and normal morphology of the cavernous body compared with VEGF-A administration. This combination therapy will be useful to treat ED patients with a severely damaged cavernous body.
© 2013 International Society for Sexual Medicine.

Entities:  

Keywords:  Adrenomedullin; Angiopoietin-1; Diabetes And Erectile Function; Erectile Dysfunction; Vascular Endothelial Growth Factor

Mesh:

Substances:

Year:  2013        PMID: 23651347     DOI: 10.1111/jsm.12177

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  3 in total

1.  Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice.

Authors:  Hiroaki Nishimatsu; Etsu Suzuki; Yasuho Saito; Aya Niimi; Akira Nomiya; Hiroshi Fukuhara; Haruki Kume; Yukio Homma
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

2.  Neuromedin B Restores Erectile Function by Protecting the Cavernous Body and the Nitrergic Nerves from Injury in a Diabetic Rat Model.

Authors:  Hiroaki Nishimatsu; Etsu Suzuki; Yasuho Saito; Aya Niimi; Akira Nomiya; Daisuke Yamada; Yukio Homma
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 3.  Research in pharmacotherapy for erectile dysfunction.

Authors:  Ji-Kan Ryu; Jun-Kyu Suh; Arthur L Burnett
Journal:  Transl Androl Urol       Date:  2017-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.